BOOKER T DALTON

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology ATLANTA, GA NPI 1477557130

General Payments — all program years on this page

$1,721.48

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 93
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $433.17 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $433.1720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $93.037
2019 $109.747
2020 $41.923
2021 $207.1813
2022 $434.0824
2023 $402.3619
2024 $433.1720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1075850313 Celltrion USA Inc. $21.40 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078524966 Janssen Biotech, Inc. $25.76 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078525680 Janssen Biotech, Inc. $14.43 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103530635 ABBVIE INC. $16.17 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103530637 ABBVIE INC. $19.86 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108477933 Olympus America Inc. $19.94 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108477936 Olympus America Inc. $32.63 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114032547 Regeneron Healthcare Solutions, Inc. $15.74 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114032549 Regeneron Healthcare Solutions, Inc. $15.92 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114032551 Regeneron Healthcare Solutions, Inc. $16.33 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119335929 Medtronic, Inc. $34.03 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131730278 PFIZER INC. $22.53 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136066321 Lilly USA, LLC $13.59 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137523426 Takeda Pharmaceuticals U.S.A., Inc. $16.67 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137523430 Takeda Pharmaceuticals U.S.A., Inc. $16.07 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139973265 GENZYME CORPORATION $38.41 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139973307 GENZYME CORPORATION $23.69 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141809662 Merck Sharp & Dohme LLC $23.52 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141809664 Merck Sharp & Dohme LLC $24.63 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153484014 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.85 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.